Descripción
The protein expression market is projected to grow from $2.7 billion in 2024 to $6.3 billion by 2035, representing a CAGR of 8.0%, during the forecast period, till 2035.
Although protein therapeutics offer significant profit margins and have demonstrated the potential to treat a myriad of disease indications, they are generally associated with high costs of development and complex manufacturing protocols. This has prompted various industry stakeholders to adopt novel protein expression systems with advanced features for the production of recombinant proteins. The protein expression market is presently characterized by the presence of both niche, specialty protein expression companies, focused solely on expressing proteins, and one-stop-shops, which have, over time, acquired an extensive range of capabilities to cater to essentially all the requirements of sponsors including custom protein expression services.
It is worth highlighting that there is a significant rise in the interest of stakeholders in protein expression segment; this can be validated by the increase in partnership and funding activity within this domain. Further, the growing demand for personalized and precision medicne has compelled the players engaged in this domain to expand their existing capabilities / capacities in order to accommodate the future needs of their clients. In addition, as mentioned earlier, technological advancements in this field, coupled to the advances in the expression host organisms, has further expeditated the growth of protein expression segment.
Market landscape of key players in the protein expression industry- The protein expression market is highly fragmented, featuring the presence of established companies, as well as emerging start-ups. Most of the players were established pre-1980; further, the growing demand for protein-based drugs has prompted various start-ups to enter in this domain. Around 50% of the key players engaged in the protein expression market are headquartered in North America; of these, ~45% are very large firms.
Majority of the key players offer prokaryotic expression system, followed by mammalian expression system. Further, it is worth highlighting that around 55% of the key players offer more than three types of protein expression systems. Presently, over 80% of the protein expression providers offer custom protein expression services. This is followed by key players offering expression vectors (55%).
Research Methodology
Our analysts have performed an accurate examination of the various aspects of the global market leveraging avant-garde primary and secondary sources of data collection. The report has gathered the necessary data and information from several reliable sources. Additionally, the report offers many strategic recommendations for companies involved in this ever-growing business sector to help them attain a competitive edge in the protein expression market.
Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs.
To view more details on this report, click on the link
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
We specialise in analysing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way.
The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organisations worldwide.
Contact:
Roots Analysis
+1 (415) 800 3415